0001209191-21-023838.txt : 20210331
0001209191-21-023838.hdr.sgml : 20210331
20210331181758
ACCESSION NUMBER: 0001209191-21-023838
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210329
FILED AS OF DATE: 20210331
DATE AS OF CHANGE: 20210331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HANLY ANN M.
CENTRAL INDEX KEY: 0001854528
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 21795133
MAIL ADDRESS:
STREET 1: C/O VIR BIOTECHNOLOGY, INC.
STREET 2: 499 ILLINOIS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-29
0
0001706431
Vir Biotechnology, Inc.
VIR
0001854528
HANLY ANN M.
C/O VIR BIOTECHNOLOGY, INC.
499 ILLINOIS STREET, SUITE 500
SAN FRANCISCO
CA
94158
0
1
0
0
Chief Technology Officer
Common Stock
2021-03-29
4
A
0
30000
0.00
A
30000
D
Employee Stock Option (Right to Buy)
48.38
2021-03-29
4
A
0
60000
0.00
A
2031-03-28
Common Stock
60000
60000
D
1/4 of the shares subject to the stock option vest and become exercisable on March 29, 2022, and the remainder vest in 36 equal monthly installments thereafter.
/s/ Howard Horn, Attorney-in-Fact
2021-03-31